Contact this trialFirst, we need to learn more about you.
Vaccine Response After CAR-T Therapy for B-Cell Lymphoma
Recruiting1 awardPhase 1
Seattle, Washington
This trial will use an inactivated rabies virus vaccine to test immune function in patients who have undergone a new cancer treatment called CARTx. A group of healthy volunteers will also be enrolled to provide a comparison. CARTx is a new treatment for patients with cancer of the B-cells, and the long-term effects of CARTx on immune function are not yet well understood. This trial may help doctors better understand immune function and improve outcomes for this growing population of high-risk individuals.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service